NeoGenomics (NEO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael ...

Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...

For a thorough assessment of NGS stock, go to TipRanks’ Stock Analysis page. Trending Articles Natural Gas Services Group NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

We came across a bullish thesis on SOPHiA GENETICS SA (SOPH) on Two Natural Cap’s Substack by Two Natural Capital. In this ...

Fapon, a global leading life sciences company, is excited to participate in the upcoming MEDICA 2024 International Trade Fair, which will take place from November 11-14 in Düsseldorf, Germany. Fapon ...

QGEN delivers another solid performance in the third quarter of 2024, with both the top and bottom lines surpassing estimates ...

Baron Funds, an investment management firm, released its “Baron Global Advantage Fund” third quarter 2024 investor letter. A ...

Beyond analysts' top -and-bottom-line estimates for Qiagen (QGEN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA ...

Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ETCorporate ParticipantsSalli Schwartz - Vice President of ...